Literature DB >> 32745585

Metabolic fate in adult and pediatric population of steviol glycosides produced from stevia leaf extract by different production technologies.

Sidd Purkayastha1, David Kwok2.   

Abstract

More than 60 naturally occurring steviol glycosides in the Stevia rebaudiana Bertoni plant share a similar molecular structure with an aglycone steviol backbone conjugated with β- and α-glycosidic bonds to different sugar moieties. These glycosides are naturally produced in different quantities within the stevia leaf. Certain minor glycosides with superior sensory attributes, such as Reb D and Reb M, are found less than 0.1% in traditional stevia leaves. New technologies can now produce better tasting steviol glycosides by using enzymatic conversion of stevioside and Reb A, which are abundant in stevia leaf. Several regulatory authorities recently evaluated steviol glycosides produced by enzymatic conversion of stevia leaf extract and approved them safe for human consumption. Steviol glycosides undergo microbial hydrolysis in the colon to generate steviol, which is absorbed and metabolized into steviol glucuronide, and excreted primarily via human's urine. Previous studies have shown the hydrolysis of highly purified individual steviol glycosides extracted from stevia leaf are converted to steviol in the presence of colonic microbiota of adults. Since colonic microbiota of children may be different from adults, this study investigates the metabolic fate in the colonic microbiota of adults and children of the minor steviol glycosides produced by extraction and enzymatic conversion of major steviol glycosides from stevia leaf. Several in vitro incubation tests were conducted in human fecal homogenates collected from adult and pediatric populations with steviol glycoside test samples comprised of a complex stevia leaf extract, a blend of minor glycosides isolated from stevia extract and two mixtures of steviol glycosides produced by enzymatic conversion of Reb A to larger molecules by attaching glucose units via β- or α-glycosidic bonds. Results from these studies clearly demonstrate steviol glycosides produced by extraction from stevia leaf, or enzymatic conversion of stevia leaf extract, share the same metabolic fate in the human gut microbiota from adults and children. Considering a common metabolite structure and a shared metabolic fate in all ages, safety data for individual steviol glycosides can be used to support safety of all steviol glycosides produced by extraction and enzymatic conversion of stevia leaf extract.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anaerobic; Bioconversion; Extraction; Glycosylation; Human; Safety; Stevia extract; Stevia leaf extract; Steviol glycosides; in vitro metabolism

Mesh:

Substances:

Year:  2020        PMID: 32745585     DOI: 10.1016/j.yrtph.2020.104727

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  3 in total

1.  Safety of the proposed amendment of the specifications for enzymatically produced steviol glycosides (E 960c): Rebaudioside D produced via enzymatic bioconversion of purified stevia leaf extract.

Authors:  Maged Younes; Gabriele Aquilina; Karl-Heinz Engel; Paul J Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Rainer Gürtler; Ursula Gundert-Remy; Trine Husøy; Melania Manco; Wim Mennes; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Matthew Wright; José Manuel Barat Baviera; Gisela Degen; Lieve Herman; Jean-Charles Leblanc; Detlef Wölfle; Jaime Aguilera; Alessandra Giarola; Camilla Smeraldi; Giorgia Vianello; Laurence Castle
Journal:  EFSA J       Date:  2022-05-16

Review 2.  Diet and the Microbiota-Gut-Brain Axis: Sowing the Seeds of Good Mental Health.

Authors:  Kirsten Berding; Klara Vlckova; Wolfgang Marx; Harriet Schellekens; Catherine Stanton; Gerard Clarke; Felice Jacka; Timothy G Dinan; John F Cryan
Journal:  Adv Nutr       Date:  2021-07-30       Impact factor: 8.701

3.  Safety evaluation of glucosylated steviol glycosides as a food additive in different food categories.

Authors:  Maged Younes; Gabriele Aquilina; Karl-Heinz Engel; Paul J Fowler; Maria Jose Frutos Fernandez; Peter Fürst; Rainer Gürtler; Ursula Gundert-Remy; Trine Husøy; Melania Manco; Wim Mennes; Peter Moldeus; Sabina Passamonti; Romina Shah; Ine Waalkens-Berendsen; Detlef Wölfle; Matthew Wright; Jose Manuel Barat; Gisela Degen; Lieve Herman; Jean-Charles Leblanc; Jaime Aguilera; Alessandra Giarola; Ana Maria Rincon; Camilla Smeraldi; Giorgia Vianello; Laurence Castle
Journal:  EFSA J       Date:  2022-02-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.